1.
Ebert KM, Posid T, Dall CP, Shah KK, Broutian T, Harbrecht MT, et al. Promoting patient followup treatment with intra-detrusor onabotulinumtoxinA for overactive bladder. CUAJ [Internet]. 2021 Jan. 4 [cited 2026 Apr. 28];15(8):E405-11. Available from: https://cuaj.ca/index.php/journal/article/view/6983